Bell Bank lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 2.5% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,909 shares of the healthcare conglomerate’s stock after selling 127 shares during the quarter. Bell Bank’s holdings in UnitedHealth Group were worth $2,320,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of the business. Chelsea Counsel Co. bought a new position in UnitedHealth Group in the 4th quarter valued at $27,000. Freedom Wealth Alliance LLC purchased a new position in UnitedHealth Group during the fourth quarter worth about $31,000. Legend Financial Advisors Inc. purchased a new stake in shares of UnitedHealth Group in the 3rd quarter valued at about $37,000. Investors Research Corp increased its position in shares of UnitedHealth Group by 51.1% in the fourth quarter. Investors Research Corp now owns 71 shares of the healthcare conglomerate’s stock worth $38,000 after purchasing an additional 24 shares during the last quarter. Finally, Bourgeon Capital Management LLC lifted its position in UnitedHealth Group by 192.3% during the fourth quarter. Bourgeon Capital Management LLC now owns 76 shares of the healthcare conglomerate’s stock valued at $40,000 after purchasing an additional 50 shares during the last quarter. 92.61% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of research firms have recently issued reports on UNH. StockNews.com downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a report on Wednesday, June 14th. Cantor Fitzgerald initiated coverage on UnitedHealth Group in a research report on Thursday, April 20th. They set an “overweight” rating and a $591.00 price objective on the stock. Loop Capital increased their price target on shares of UnitedHealth Group from $590.00 to $600.00 and gave the company a “buy” rating in a research report on Monday, April 17th. JPMorgan Chase & Co. reduced their target price on shares of UnitedHealth Group from $595.00 to $562.00 in a report on Tuesday, May 30th. Finally, Royal Bank of Canada restated an “outperform” rating and set a $592.00 price target on shares of UnitedHealth Group in a research report on Monday, April 17th. One analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average price target of $592.68.
Insider Buying and Selling
UnitedHealth Group Stock Performance
NYSE:UNH opened at $480.64 on Monday. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a twelve month low of $445.68 and a twelve month high of $558.10. The stock has a market cap of $447.49 billion, a P/E ratio of 21.98, a price-to-earnings-growth ratio of 1.41 and a beta of 0.66. The firm’s fifty day simple moving average is $483.72 and its 200 day simple moving average is $489.73.
UnitedHealth Group (NYSE:UNH – Free Report) last released its quarterly earnings results on Friday, April 14th. The healthcare conglomerate reported $6.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.24 by $0.02. UnitedHealth Group had a net margin of 6.16% and a return on equity of 27.05%. The company had revenue of $91.93 billion during the quarter, compared to the consensus estimate of $89.77 billion. During the same period in the prior year, the firm earned $5.49 earnings per share. UnitedHealth Group’s revenue was up 14.7% on a year-over-year basis. As a group, research analysts predict that UnitedHealth Group Incorporated will post 24.86 EPS for the current year.
UnitedHealth Group Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 27th. Investors of record on Monday, June 19th were paid a $1.88 dividend. This represents a $7.52 annualized dividend and a dividend yield of 1.56%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.65. The ex-dividend date was Thursday, June 15th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 34.39%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- MarketBeat Week in Review – 6/26 – 6/30
- Tesla: Can Downgrades Make Sense After A 170% Rally?
- Buffett’s Berkshire Increases Stake In Occidental Petroleum (OXY)
- Rally Gains Momentum On Soft PCE Data
- Bank of America, JPMorgan, Goldman Sachs Set For Dividend Growth?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
